Company Disclosures › Sub-category

R&D Initiatives

1 article

SMS Pharma Q2 PAT Up 57% YoY to ₹40 Crore

SMS Pharmaceuticals reported Q2FY27 revenue growth of 30% YoY to ₹316 crore and a 57% YoY PAT increase to ₹40 crore, driven by volume growth and improved price realization. EBITDA margin expanded 145